These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S. East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516 [Abstract] [Full Text] [Related]
3. Twice-weekly, directly observed treatment for HIV-infected and uninfected tuberculosis patients: cohort study in rural South Africa. Davies GR, Connolly C, Sturm AW, McAdam KP, Wilkinson D. AIDS; 1999 May 07; 13(7):811-7. PubMed ID: 10357380 [Abstract] [Full Text] [Related]
4. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium. Vernon A, Burman W, Benator D, Khan A, Bozeman L. Lancet; 1999 May 29; 353(9167):1843-7. PubMed ID: 10359410 [Abstract] [Full Text] [Related]
6. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society. Monaldi Arch Chest Dis; 1994 Sep 29; 49(4):327-45. PubMed ID: 8000420 [Abstract] [Full Text] [Related]
7. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy. Swaminathan S, Deivanayagam CN, Rajasekaran S, Venkatesan P, Padmapriyadarsini C, Menon PA, Ponnuraja C, Dilip M. Natl Med J India; 2008 Sep 29; 21(1):3-8. PubMed ID: 18472696 [Abstract] [Full Text] [Related]
8. Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa. Kassim S, Sassan-Morokro M, Ackah A, Abouya LY, Digbeu H, Yesso G, Coulibaly IM, Coulibaly D, Whitaker PJ, Doorly R. AIDS; 1995 Oct 29; 9(10):1185-91. PubMed ID: 8519456 [Abstract] [Full Text] [Related]
10. Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana. Chideya S, Winston CA, Peloquin CA, Bradford WZ, Hopewell PC, Wells CD, Reingold AL, Kenyon TA, Moeti TL, Tappero JW. Clin Infect Dis; 2009 Jun 15; 48(12):1685-94. PubMed ID: 19432554 [Abstract] [Full Text] [Related]
13. Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India. Tripathy S, Anand A, Inamdar V, Manoj MM, Khillare KM, Datye AS, Iyer R, Kanoj DM, Thakar M, Kale V, Pereira M, Risbud AR. Indian J Med Res; 2011 May 15; 133(5):521-8. PubMed ID: 21623038 [Abstract] [Full Text] [Related]
15. Second episode of tuberculosis in an HIV-infected child: relapse or reinfection? Schaaf HS, Gie RP, van Rie A, Seifart HI, van Helden PD, Cotton MF. J Infect; 2000 Jul 15; 41(1):100-3. PubMed ID: 11041705 [Abstract] [Full Text] [Related]
18. Empiric antituberculosis treatment: benefits for earlier diagnosis and treatment of tuberculosis. Anglaret X, Saba J, Perronne C, Lacassin F, Longuet P, Leport C, Vildé JL. Tuber Lung Dis; 1994 Oct 15; 75(5):334-40. PubMed ID: 7841426 [Abstract] [Full Text] [Related]
19. Reintroducing antituberculosis therapy after Stevens-Johnson syndrome in human immunodeficiency virus-infected patients with tuberculosis: role of desensitization. Kura MM, Hira SK. Int J Dermatol; 2001 Jul 15; 40(7):481-4. PubMed ID: 11679013 [No Abstract] [Full Text] [Related]